Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes.

Viruses - 14 Jan 2022

Chatterjee Debashree, Tauzin Alexandra, Laumaea Annemarie, Gong Shang Yu, Bo Yuxia, Guilbault Aurélie, Goyette Guillaume, Bourassa Catherine, Gendron-Lepage Gabrielle, Medjahed Halima, Richard Jonathan, Moreira Sandrine, Côté Marceline, Finzi Andrés

Abstract excerpt

The rapid emergence of SARS-CoV-2 variants is fueling the recent waves of the COVID-19 pandemic. Here, we assessed ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 Spikes. Both these variants carry some mutations shared by other emerging variants. Some of the pivotal mutations such as N501Y and E484K in the receptor-binding domain (RBD) detected in B.1.1.7 (Alpha), B.1.351 (Beta) and P.1 (Gamma) are now...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Vaccines

Share to HEK293 Cells

Share to Neutralization Tests

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 35062348
DOI: 10.3390/v14010144
PMCID: PMC8780535

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes.PMID 35062348Read ↗

Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2.Semantic proximity Read ↗

Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.Semantic proximity Read ↗

E484K and N501Y SARS-CoV 2 spike mutants Increase ACE2 recognition but reduce affinity for neutralizing antibody.Semantic proximity Read ↗

SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.Semantic proximity Read ↗

Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variantsSemantic proximity Read ↗

Effect of SARS-CoV-2 spike mutations on animal ACE2 usage and in vitro neutralization sensitivitySemantic proximity Read ↗

Characterization of SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta) and B.1.618 on cell entry, host range, and sensitivity to convalescent plasma and ACE2 decoy receptorSemantic proximity Read ↗

Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529Semantic proximity Read ↗

In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.Semantic proximity Read ↗

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune EvasionSemantic proximity Read ↗

Evolution of the SARS-CoV-2 spike protein in the human hostSemantic proximity Read ↗

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.